Pharmaceutical - Antibiotics and Infectious diseases, Pharmaceutical

Filter

Popular Filters

1 to 25 of 237 results

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

AstraZeneca to spin-out early-stage antibiotic R&D into stand-alone company

28-02-2015

Anglo-Swedish pharma major AstraZeneca is changing the structure of its small-molecule early-stage anti-infectives…

Antibiotics and Infectious diseasesAstraZenecaMergers & AcquisitionsPharmaceuticalResearchUK

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

26-02-2015

Jim O'Neill, chair of the UK government's review on antimicrobial resistance (AMR), spoke of the need…

AMRAntibiotics and Infectious diseasesPharma SummitPharmaceuticalUK

US FDA approves new antibacterial drug Avycaz

US FDA approves new antibacterial drug Avycaz

26-02-2015

The US Food and Drug Administration has approved antibacterial drug Avycaz (ceftazidime-avibactam) to…

ActavisAntibiotics and Infectious diseasesceftazidime-avibactamForest PharmaceuticalsPharmaceuticalRegulationUSA

Fujifilm's favipiravir performs well in early-stage Ebola study

Fujifilm's favipiravir performs well in early-stage Ebola study

25-02-2015

A study conducted in Guinea has shown that Fujifilm’s favipiravir halves mortality rates in patients…

Antibiotics and Infectious diseasesfavipiravirFujifilmGuineaPharmaceuticalResearch

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

Regulatory shakeup needed to fight antimicrobial resistance, says PwC report

Regulatory shakeup needed to fight antimicrobial resistance, says PwC report

11-02-2015

Greater flexibility and guidance in clinical trial design, along with quicker review times, are needed…

Antibiotics and Infectious diseasesPharmaceuticalPwCResearchSocial Issues

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

FDA's anti-infective committee recommends Astellas' Cresemba

FDA's anti-infective committee recommends Astellas' Cresemba

23-01-2015

The US Food and Drug Administration’s Anti-Infective Drugs Advisory Committee has voted unanimously…

Antibiotics and Infectious diseasesAstellasCresembaPharmaceuticalRegulationUSA

ORCHID project aims to slash development time of tuberculosis drugs

ORCHID project aims to slash development time of tuberculosis drugs

14-01-2015

A collaborative project led by a scientist from UK pharma major GlaxoSmithKline has identified new compounds…

Antibiotics and Infectious diseasesGSKIsoniazidPharmaceuticalResearch

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

Roche, Meiji and Fedora team up to commercialize antibiotic OP0595

13-01-2015

Swiss pharma major Roche, Japanese pharma company Meiji Seika and private biotech company Fedora have…

Antibiotics and Infectious diseasesMeiji Seika PharmaOP0595PharmaceuticalResearchRoche

Drug launch and Ph III trial watch list for top therapeutic areas

13-01-2015

The therapeutics market is buzzing with activity, as several promising therapies are progressing to Phase…

Antibiotics and Infectious diseasesBristol-Myers SquibbCardio-vascularCosentyxGlaxoSmithKlineInflammatory diseasesLCZ-696Markets & MarketingneratinibNovartisOncologyOpdivoPharmaceuticalPuma BiotechnologyResearchSanofiVaccines

Russia’s Nanolek commissions plant for production of nano-based drugs

12-01-2015

Russia's Nanolek has officially commissioned a new facility for the production of drugs for the treatment…

Antibiotics and Infectious diseasesCardio-vascularNanolekOncologyPharmaceuticalProductionRussia

SinSa Labs signs license agreement for technology platform leading to new antibiotics

SinSa Labs signs license agreement for technology platform leading to new antibiotics

09-01-2015

Singapore-based SinSa Labs has signed a license agreement with Singapore Health Services and technology…

Antibiotics and Infectious diseasesDorzidinLicensingPharmaceuticalResearchSingaporeSinSa Labs

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

Potential new MRSA-killing antibiotic developed by mining microbial 'dark matter'

08-01-2015

Researchers at Northeastern University in Boston, MA, and NovoBiotic Pharmaceuticals have made a breakthrough…

Antibiotics and Infectious diseasesMicrobiologyNovoBiotic PharmaceuticalsPharmaceuticalResearchTeixobactin

BioCryst's Rapivab approved by FDA to treat influenza

BioCryst's Rapivab approved by FDA to treat influenza

23-12-2014

USA-based BioCryst Pharmaceuticals has received approval from the US Food and Drug Administration for…

Antibiotics and Infectious diseasesBioCryst PharmaceuticalsperamivirPharmaceuticalRegulationUSA

FDA approves new antibacterial drug Zerbaxa

20-12-2014

The US Food and Drug Administration has approved Cubist Pharmaceuticals’Zerbaxa (ceftolozane/tazobactam)…

Antibiotics and Infectious diseasesCubist PharmaceuticalsMerck & CoPharmaceuticalRegulationUSAZerbaxa

FDA approves Alcon’s Xtoro to treat swimmer’s ear

FDA approves Alcon’s Xtoro to treat swimmer’s ear

18-12-2014

The US Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used…

Acute otitis externaAlcon LaboratoriesAntibiotics and Infectious diseasesHealthNovartisPharmaceuticalRegulationUSAXtoro

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

Janssen commits $30 million to USAID agreement to fight antibiotic-resistant bacteria

12-12-2014

US health care giant Johnson & Johnson’s subsidiary Janssen has made an agreement with the United States…

Antibiotics and Infectious diseasesJanssenPharmaceuticalResearchUSA

Africa will be hardest hit region of anti-microbial resistance, warns report

Africa will be hardest hit region of anti-microbial resistance, warns report

11-12-2014

Low income countries are likely to suffer the greatest loss of population and economic output if anti-microbial…

Antibiotics and Infectious diseasesFinancialPharmaceuticalResearchRest of the WorldSub-Saharan Africa

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

09-12-2014

Effective malaria control has dramatically reduced the number of people dying from the disease since…

Anti-viralsAntibiotics and Infectious diseasesPharmaceuticalResearchRest of the World

FDA advisory panel backs Actavis’ ceftazidime-avibactam

06-12-2014

Ireland-headquartered generic drugs major Actavis says that the Anti-Infective Drugs Advisory Committee…

ActavisAntibiotics and Infectious diseasesAstraZenecaceftazidime-avibactamPharmaceuticalRegulationUSA

Urgent action needed to address Clostridium difficile infections in Europe

Urgent action needed to address Clostridium difficile infections in Europe

03-12-2014

Urgent action is needed to address the current issues relating to the management of health care-acquired…

Antibiotics and Infectious diseasesEuropeEuropean ParliamentPharmaceuticalPolitics

FDA approves Sanofi’s Priftin for latent TB

FDA approves Sanofi’s Priftin for latent TB

03-12-2014

French pharma major Sanofi says that the US Food and Drug Administration has approved Priftin (rifapentine),…

Antibiotics and Infectious diseasesPharmaceuticalPriftinRegulationSanofiUSA

1 to 25 of 237 results

COMPANY SPOTLIGHT

Menarini

Back to top